Davis Marie Y, Keene C Dirk, Jayadev Suman, Bird Thomas
Department of Neurology, University of Washington, Seattle, WA, USA Neurology, VA Puget Sound Health Care System, Seattle, WA, USA.
Department of Pathology, University of Washington, Seattle, WA, USA.
J Huntingtons Dis. 2014;3(2):209-17. doi: 10.3233/JHD-140111.
Dementia is a common feature in both Huntington's disease (HD) and Alzheimer's disease (AD), as well as in the general elderly population. Few studies have examined elderly HD patients with dementia for neuropathologic evidence of both HD and AD.
We present neuropathological findings in a retrospective case series of 15 elderly HD patients (ages 60-91 years), 11 of whom had prominent clinical dementia.
Post-mortem brain tissue was examined and stained for evidence of both HD and AD including Vonsattel grading and Htt-repeat expansion, Bielskowsky, tau, β amyloid, and TDP43 immunostaining.
Mean age at death was 76.8 years, mean disease duration was 18.6 years, and mean CAG repeat expansion was 42. Evidence of AD in addition to HD pathology was present in 9 of 11 (82%) patients with prominent dementia, suggesting that AD may be more commonly co-occurring with HD than previously appreciated. Two patients had only HD as the basis of dementia and four patients did not have prominent dementia. One patient with marked parkinsonian features was not L-dopa responsive and had no substantia nigra Lewy bodies at autopsy.
Our study suggests that AD may frequently contribute to cognitive decline in elderly HD patients which complicates the assessment and management of such individuals. Further study is needed to determine if there is a higher incidence of AD in persons with HD compared to the general population. In addition, our series includes one HD patient whose clinical features masqueraded as Parkinson's disease but was not responsive to levodopa therapy.
痴呆是亨廷顿舞蹈病(HD)、阿尔茨海默病(AD)以及普通老年人群中的常见特征。很少有研究针对患有痴呆的老年HD患者检查HD和AD两者的神经病理学证据。
我们呈现了15例老年HD患者(年龄60 - 91岁)的回顾性病例系列的神经病理学发现,其中11例有明显的临床痴呆症状。
对尸检脑组织进行检查并染色,以寻找HD和AD的证据,包括冯萨特尔分级和亨廷顿蛋白(Htt)重复序列扩增、 Bielschowsky染色、tau蛋白、β淀粉样蛋白和TDP43免疫染色。
平均死亡年龄为76.8岁,平均病程为18.6年,平均CAG重复序列扩增数为42。在11例有明显痴呆症状的患者中,有9例(82%)除HD病理改变外还存在AD证据,这表明AD与HD同时发生的情况可能比之前认为的更常见。2例患者仅以HD作为痴呆的病因,4例患者没有明显的痴呆症状。1例有明显帕金森特征的患者对左旋多巴无反应,尸检时黑质无路易小体。
我们的研究表明,AD可能经常导致老年HD患者的认知功能下降,这使得对此类患者的评估和管理变得复杂。需要进一步研究以确定HD患者中AD的发病率是否高于普通人群。此外,我们的系列研究包括1例HD患者,其临床特征伪装成帕金森病,但对左旋多巴治疗无反应。